AF
CGON icon

Allworth Financial’s CG Oncology CGON Stock Holding History

Allworth Financial’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55K Sell
64
-8
-11% -$523 ﹤0.01% 4176
2026
Q1 		$4.87K Buy
72
+16
+29% +$907 ﹤0.01% 3975
2025
Q4 		$2.33K Sell
56
-1
-2% -$41 ﹤0.01% 4063
2025
Q3 		$2.3K Sell
57
-53
-48% -$1.54K ﹤0.01% 3937
2025
Q2 		$2.86K Buy
110
+78
+244% +$1.88K ﹤0.01% 3555
2025
Q1 		$689 Buy
+32
New +$900 ﹤0.01% 3597

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allworth Financial's CGON Position: Q2 2026 in Review

Allworth Financial reduced its CG Oncology (CGON) stake by 11% in Q2 2026, selling an estimated $523 and leaving 64 shares worth $4.55K. The position accounts for ﹤0.01% of the portfolio, ranked #4176.

Allworth Financial first reported a position in CGON in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.87K in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Allworth Financial held 64 shares of CG Oncology worth $4.55K as of Q2 2026.
  • Allworth Financial sold 8 CG Oncology shares in Q2 2026, an estimated $523.
  • CG Oncology made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4176 holding.
  • Allworth Financial first reported a position in CG Oncology in Q1 2025 and has held it in 6 quarters since.
  • Allworth Financial's CG Oncology position peaked at $4.87K in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.